{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:41:58Z","timestamp":1774644118495,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12185-022-03463-0","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T15:02:43Z","timestamp":1664636563000},"page":"456-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency"],"prefix":"10.1007","volume":"117","author":[{"given":"Michael J.","family":"Hochman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Douglas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Karantanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan M.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Gojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison R.","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"DeZern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"3463_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"3463_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.25792","volume":"95","author":"E Jabbour","year":"2020","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020;95:691\u2013709.","journal-title":"Am J Hematol"},{"key":"3463_CR3","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumors: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"3463_CR4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00277-018-3402-x","volume":"97","author":"P Boddu","year":"2018","unstructured":"Boddu P, Chihara D, Masarova L, Pemmaraju N, Patel KP, Verstovsek S. The co-occurrence of driver mutations in chronic myeloproliferative neoplasms. Ann Hematol. 2018;97:2071\u201380.","journal-title":"Ann Hematol"},{"key":"3463_CR5","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1200\/JCO.2012.47.8669","volume":"32","author":"O Yamada","year":"2014","unstructured":"Yamada O, Mahfoudhi E, Plo I, Ozaki K, Nakatake M, Akiyama M, et al. Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F clone. J Clin Oncol. 2014;32:e76-79.","journal-title":"J Clin Oncol"},{"key":"3463_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1470-2045(07)70206-1","volume":"8","author":"A Kr\u00e4mer","year":"2007","unstructured":"Kr\u00e4mer A, Reiter A, Kruth J, Erben P, Hochhaus A, M\u00fcller M, et al. JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol. 2007;8:658\u201360.","journal-title":"Lancet Oncol"},{"key":"3463_CR7","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/sj.leu.2404730","volume":"21","author":"M Bornh\u00e4user","year":"2007","unstructured":"Bornh\u00e4user M, Mohr B, Oelschlaegel U, Bornh\u00e4user P, Jacki S, Ehninger G, et al. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia. 2007;21:1824\u20136.","journal-title":"Leukemia"},{"key":"3463_CR8","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.3816\/CLM.2009.n.080","volume":"9","author":"SRK Pingali","year":"2009","unstructured":"Pingali SRK, Mathiason MA, Lovrich SD, Go RS. Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation. Clin Lymphoma Myeloma. 2009;9:E25-29.","journal-title":"Clin Lymphoma Myeloma"},{"key":"3463_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1182\/blood-2012-11-467787","volume":"121","author":"X Wang","year":"2013","unstructured":"Wang X, Tripodi J, Kremyanskaya M, Blouin A, Roda P, Hoffman R, et al. BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia. Blood. 2013;121:1238\u20139.","journal-title":"Blood"},{"key":"3463_CR10","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","volume":"22","author":"N Cambier","year":"2008","unstructured":"Cambier N, Renneville A, Cazaentre T, Soenen V, Cossement C, Giraudier S, et al. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia. 2008;22:1454\u20135.","journal-title":"Leukemia"},{"key":"3463_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.leukres.2007.10.018","volume":"32","author":"Y-K Kim","year":"2008","unstructured":"Kim Y-K, Shin M-G, Kim H-R, Yang D-H, Cho S-H, Lee J-J, et al. Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders. Leuk Res. 2008;32:993\u20135.","journal-title":"Leuk Res"},{"key":"3463_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12185-013-1480-z","volume":"99","author":"W Xu","year":"2014","unstructured":"Xu W, Chen B, Tong X. Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation. Int J Hematol. 2014;99:87\u201390.","journal-title":"Int J Hematol"},{"key":"3463_CR13","unstructured":"Chronic Myeloid Leukemia - Cancer Stat Facts [Internet]. SEER. [cited 2021 Jul 27]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/cmyl.html."},{"key":"3463_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/modpathol.2017.182","volume":"31","author":"CR Soderquist","year":"2018","unstructured":"Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, et al. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018;31:690\u2013704.","journal-title":"Mod Pathol"},{"key":"3463_CR15","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1182\/blood-2011-07-365007","volume":"118","author":"L Pieri","year":"2011","unstructured":"Pieri L, Spolverini A, Scappini B, Occhini U, Birtolo S, Bosi A, et al. Concomitant occurrence of BCR-ABL and JAK2V617F mutation. Blood. 2011;118:3445\u20136.","journal-title":"Blood"},{"key":"3463_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist. 2007;12:20\u201337.","journal-title":"Oncologist"},{"key":"3463_CR17","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1182\/blood-2008-07-172148","volume":"114","author":"MS Fernandes","year":"2009","unstructured":"Fernandes MS, Reddy MM, Gonneville JR, DeRoo SC, Podar K, Griffin JD, et al. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair. Blood. 2009;114:1813\u20139.","journal-title":"Blood"},{"key":"3463_CR18","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1182\/blood.2020010402","volume":"138","author":"C Marcault","year":"2021","unstructured":"Marcault C, Zhao L-P, Maslah N, Verger E, de Oliveira RD, Soret-Dulphy J, et al. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 2021;138:2142\u20138.","journal-title":"Blood"},{"key":"3463_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/10245332.2018.1466428","volume":"23","author":"R Kotchetkov","year":"2018","unstructured":"Kotchetkov R, Ellison E, McLean J, Pressnail B, Nay D. Synchronous dual hematological malignancies: new or underreported entity? Hematology. 2018;23:596\u20139.","journal-title":"Hematology"},{"key":"3463_CR20","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00277-019-03778-9","volume":"98","author":"T Chalopin","year":"2019","unstructured":"Chalopin T, Vallet N, Arbion F, Barin C, Rault E, Villate A, et al. Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo2study). Ann Hematol. 2019;98:2367\u201377.","journal-title":"Ann Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03463-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03463-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T15:42:07Z","timestamp":1677512527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03463-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3463"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03463-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"8 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}